Results 241 to 250 of about 720,989 (310)

CAR-T in the Treatment of Solid Tumors-A Review of Current Research and Future Perspectives. [PDF]

Int J Mol Sci
Picheta N, Piekarz J, Daniłowska K, Szklener K, Mańdziuk S.   +4 more
europepmc   +1 more source

Living Materials Approach for In Situ Bio‐Polymers Production Using Bacillus Paralicheniformis in Microneedles

Advanced Healthcare Materials, EarlyView.
Dissolvable microneedle (MN) device containing Bacillus paralicheniformis. The polymeric matrix encapsulates and protects the bacteria, preserving their viability while enabling in situ production and release of γ‐polyglutamic acid. The bacteria are delivered into the skin via 500 µm‐long microneedles, and remain detectable on the skin 24 h post ...
Caroline Hali Alperovitz, Noa Ben David, Adi Gross, Boaz Mizrahi   +3 more
wiley   +1 more source

Clonal Hematopoiesis and Cardiovascular Disease Risk After Cancer Therapy in Patients With Solid Tumors.

JAMA Oncol
Shyr D, Pershad Y, Zhao K, Kishtagari A, Corty RW, Shinohara E, Park BH, Heimlich JB, Luo L, Bick AG.   +9 more
europepmc   +1 more source

Preoperative Angioembolization of Pediatric Solid Tumors: Does It Facilitate the Surgeon's Task? [PDF]

Maedica (Bucur)
Lamprinou Z, Kanna E, Tsanis A, Ptohis N, Skondras I.   +4 more
europepmc   +1 more source

A 3D Bioprinted Spheroid‐Laden dECM‐Enriched Osteosarcoma Model for Enhanced Drug Testing and Therapeutic Discovery

Advanced Healthcare Materials, EarlyView.
A 3D biomimetic OS model was developed by bioprinting an OS‐cell‐derived dECM‐enriched bioink with OS spheroids incorporated. The model showed upregulation of known OS prognostic markers and increased resistance to doxorubicin, compared to 2D cultures and scaffold‐free spheroids, making this a more clinically relevant platform for drug discovery ...
Margarida F. Domingues, Maria Catarina Carreira, Mafalda S. Santos, Daniela Pacheco, Frederico Castelo Ferreira, Paola Sanjuan‐Alberte, João Carlos Silva   +6 more
wiley   +1 more source

Mitophagy in the mechanisms of treatment resistance in solid tumors. [PDF]

Oncol Rev
Yan X, Ding H, Ren M, Zang L.
europepmc   +1 more source

Optimizing therapeutic outcomes with Mechanotherapy and Ultrasound Sonopermeation in solid tumors. [PDF]

PLoS Comput Biol
Koutsi M, Stylianopoulos T, Mpekris F.
europepmc   +1 more source

Point/Counterpoint: Intrathecal therapy for patients with leptomeningeal metastases from solid tumors. [PDF]

Neuro Oncol
Le Rhun E, O'Brien BJ, Pentsova E, Preusser M, Weller M, Boire A, Boire A.   +6 more
europepmc   +1 more source

Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors. [PDF]

J Immunother Cancer
Melero I, Steeghs N, Lassen U, Homicsko K, Tabernero J, Cañamero M, Roller A, Duarte J, Rossmann E, Babitzki G, Grabole N, Watson C, Habigt C, Evers S, Dejardin D, Teichgräber V, Charo J.   +16 more
europepmc   +1 more source